Company intelligence / Profile preview

Healthcare Services Acquisition Corporation

Bethesda, Maryland, United States

Ownership: Private
Development stage: Other

Overview

Healthcare Services Acquisition Corporation was a Nasdaq-listed special purpose acquisition company formed to pursue a business combination in the healthcare services sector, particularly technology-enabled healthcare services businesses in the United States and Canada. It was not an operating biotech, pharma, or healthcare products company and did not develop therapeutic programs of its own. The company completed its IPO in late 2020 and traded under the symbols HCAR, HCARU, and HCARW. After failing to consummate an initial business combination within the required timeframe, it announced its intention to dissolve and liquidate in December 2022.

Industry: Investors

Beyond the preview

Go deeper on Healthcare Services Acquisition Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Healthcare Services Acquisition Corporation.

Explore the full profile